TRAIL responses are enhanced by nuclear export inhibition in osteosarcoma

PHILLIPS, Kate, WRIGHT, Nicola, MCDERMOTT, E. and CROSS, Neil (2019). TRAIL responses are enhanced by nuclear export inhibition in osteosarcoma. Biochemical and Biophysical Research Communications, 517 (2), 383-389.

[img]
Preview
PDF
Cross_TRAILresponses(AM).pdf - Accepted Version
Creative Commons Attribution Non-commercial No Derivatives.

Download (476kB) | Preview
Official URL: https://www.sciencedirect.com/science/article/pii/...
Link to published version:: https://doi.org/10.1016/j.bbrc.2019.07.047
Related URLs:

    Abstract

    Tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is a promising antitumour agent that induces apoptosis of malignant cells through activation of death receptors. Death receptor agonistic antibodies are in clinical trials as TRAIL-mimetics, however, along with TRAIL monotherapy, show limited efficacy due to the rapid emergence of TRAILinsensitive disease. TRAIL-sensitisers, which enhance TRAIL activity or overcome TRAIL resistance, may facilitate death receptor agonists as viable anti-tumour strategies. In this study we demonstrate that the nuclear export inhibitor, Leptomycin B, is a potent in vitro TRAIL-sensitiser in osteosarcoma. Leptomycin B works synergistically with both TRAIL and death receptor 5 agonistic antibodies to induce apoptosis in TRAIL sensitive cell lines. Further, Leptomycin B sensitises TRAIL-insensitive cell lines to TRAIL and death receptor agonistic antibody mediated apoptosis. We also confirmed that aldehyde dehydrogenase (ALDH) positive cells are not resistant to the apoptotic effects of TRAIL and Leptomycin B, an important observation since ALDH positive cells can have enhanced tumorigenicity and are implicated in disease recurrence and metastasis. The nuclear export pathway, in combination with death receptor agonists, is a potential therapeutic strategy in osteosarcoma and warrants further research on clinically relevant selective inhibitors of nuclear export

    Item Type: Article
    Uncontrolled Keywords: 0304 Medicinal and Biomolecular Chemistry; 0601 Biochemistry and Cell Biology; 1101 Medical Biochemistry and Metabolomics; Biochemistry & Molecular Biology
    Identification Number: https://doi.org/10.1016/j.bbrc.2019.07.047
    Page Range: 383-389
    SWORD Depositor: Symplectic Elements
    Depositing User: Symplectic Elements
    Date Deposited: 13 Aug 2019 15:20
    Last Modified: 27 Jul 2020 01:18
    URI: http://shura.shu.ac.uk/id/eprint/24962

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics